Patient-centered digital biomarkers for allergic respiratory diseases and asthma: The ARIA-EAACI approach – ARIA-EAACI Task Force Report

Simple item page
dc.contributor.authorBousquet J.
dc.contributor.authorShamji M.H.
dc.contributor.authorAnto J.M.
dc.contributor.authorSchünemann H.J.
dc.contributor.authorCanonica G.W.
dc.contributor.authorJutel M.
dc.contributor.authorDel Giacco S.
dc.contributor.authorZuberbier T.
dc.contributor.authorPfaar O.
dc.contributor.authorFonseca J.A.
dc.contributor.authorSousa-Pinto B.
dc.contributor.authorKlimek L.
dc.contributor.authorCzarlewski W.
dc.contributor.authorBedbrook A.
dc.contributor.authorAmaral R.
dc.contributor.authorAnsotegui I.J.
dc.contributor.authorBosnic-Anticevich S.
dc.contributor.authorBraido F.
dc.contributor.authorChaves Loureiro C.
dc.contributor.authorGemicioglu B.
dc.contributor.authorHaahtela T.
dc.contributor.authorKulus M.
dc.contributor.authorKuna P.
dc.contributor.authorKupczyk M.
dc.contributor.authorMatricardi P.
dc.contributor.authorRegateiro F.S.
dc.contributor.authorSamolinski B.
dc.contributor.authorSofiev M.
dc.contributor.authorToppila-Salmi S.
dc.contributor.authorValiulis A.
dc.contributor.authorVentura M.T.
dc.contributor.authorBarbara C.
dc.contributor.authorBergmann K.C.
dc.contributor.authorBewick M.
dc.contributor.authorBlain H.
dc.contributor.authorBonini M.
dc.contributor.authorBoulet L.-P.
dc.contributor.authorBourret R.
dc.contributor.authorBrusselle G.
dc.contributor.authorBrussino L.
dc.contributor.authorBuhl R.
dc.contributor.authorCardona V.
dc.contributor.authorCasale T.
dc.contributor.authorCecchi L.
dc.contributor.authorCharpin D.
dc.contributor.authorCherrez-Ojeda I.
dc.contributor.authorChu D.K.
dc.contributor.authorCingi C.
dc.contributor.authorCosta E.M.
dc.contributor.authorCruz A.
dc.contributor.authorDevillier P.
dc.contributor.authorDramburg S.
dc.contributor.authorFokkens W.
dc.contributor.authorGotua M.
dc.contributor.authorHeffler E.
dc.contributor.authorIspayeva Z.
dc.contributor.authorIvancevich J.C.
dc.contributor.authorJoos G.
dc.contributor.authorKaidashev I.
dc.contributor.authorKraxner H.
dc.contributor.authorKvedariene V.
dc.contributor.authorLarenas-Linnemann D.E.
dc.contributor.authorLaune D.
dc.contributor.authorLourenço O.
dc.contributor.authorLouis R.
dc.contributor.authorMakela M.
dc.contributor.authorMakris M.
dc.contributor.authorMaurer M.
dc.contributor.authorMelén E.
dc.contributor.authorMicheli Y.
dc.contributor.authorMorais-Almeida M.
dc.contributor.authorMullol J.
dc.contributor.authorNiedoszytko M.
dc.contributor.authorO'Hehir R.
dc.contributor.authorOkamoto Y.
dc.contributor.authorOlze H.
dc.contributor.authorPapadopoulos N.G.
dc.contributor.authorPapi A.
dc.contributor.authorPatella V.
dc.contributor.authorPétré B.
dc.contributor.authorPham-Thi N.
dc.contributor.authorPuggioni F.
dc.contributor.authorQuirce S.
dc.contributor.authorRoche N.
dc.contributor.authorRouadi P.
dc.contributor.authorSá-Sousa A.
dc.contributor.authorSagara H.
dc.contributor.authorSastre J.
dc.contributor.authorScichilone N.
dc.contributor.authorSheikh A.
dc.contributor.authorSova M.
dc.contributor.authorSuppli Ulrik C.
dc.contributor.authorTaborda-Barata L.
dc.contributor.authorTodo-Bom A.
dc.contributor.authorTorres M.
dc.contributor.authorTsiligianni I.
dc.contributor.authorUsmani O.S.
dc.contributor.authorValovirta E.
dc.contributor.authorVasankari T.
dc.contributor.authorVieira R.J.
dc.contributor.authorWallace D.
dc.contributor.authorWaserman S.
dc.contributor.authorZidarn M.
dc.contributor.authorYorgancioglu A.
dc.contributor.authorZhang L.
dc.contributor.authorChivato T.
dc.contributor.authorOllert M.
dc.date.accessioned2024-07-22T08:02:33Z
dc.date.available2024-07-22T08:02:33Z
dc.date.issued2023
dc.description.abstractBiomarkers for the diagnosis, treatment and follow-up of patients with rhinitis and/or asthma are urgently needed. Although some biologic biomarkers exist in specialist care for asthma, they cannot be largely used in primary care. There are no validated biomarkers in rhinitis or allergen immunotherapy (AIT) that can be used in clinical practice. The digital transformation of health and health care (including mHealth) places the patient at the center of the health system and is likely to optimize the practice of allergy. Allergic Rhinitis and its Impact on Asthma (ARIA) and EAACI (European Academy of Allergy and Clinical Immunology) developed a Task Force aimed at proposing patient-reported outcome measures (PROMs) as digital biomarkers that can be easily used for different purposes in rhinitis and asthma. It first defined control digital biomarkers that should make a bridge between clinical practice, randomized controlled trials, observational real-life studies and allergen challenges. Using the MASK-air app as a model, a daily electronic combined symptom-medication score for allergic diseases (CSMS) or for asthma (e-DASTHMA), combined with a monthly control questionnaire, was embedded in a strategy similar to the diabetes approach for disease control. To mimic real-life, it secondly proposed quality-of-life digital biomarkers including daily EQ-5D visual analogue scales and the bi-weekly RhinAsthma Patient Perspective (RAAP). The potential implications for the management of allergic respiratory diseases were proposed. © 2023 The Authors. Allergy published by European Academy of Allergy and Clinical Immunology and John Wiley & Sons Ltd.
dc.identifier.DOI-ID10.1111/all.15740
dc.identifier.issn01054538
dc.identifier.urihttp://akademikarsiv.cbu.edu.tr:4000/handle/123456789/11898
dc.language.isoEnglish
dc.publisherJohn Wiley and Sons Inc
dc.rightsAll Open Access; Hybrid Gold Open Access
dc.subjectAsthma
dc.subjectBiomarkers
dc.subjectHumans
dc.subjectPatient-Centered Care
dc.subjectRespiration Disorders
dc.subjectRhinitis
dc.subjectRhinitis, Allergic
dc.subjectallergen
dc.subjectbiological marker
dc.subjectadult
dc.subjectallergic rhinitis
dc.subjectallergy
dc.subjectArticle
dc.subjectasthma
dc.subjectclinical practice
dc.subjectclinical trial
dc.subjectcontrolled study
dc.subjectdesensitization
dc.subjectdiabetes mellitus
dc.subjectdisease control
dc.subjectEuropean Quality of Life 5 Dimensions questionnaire
dc.subjectfemale
dc.subjectfollow up
dc.subjecthuman
dc.subjectmale
dc.subjectoutcome assessment
dc.subjectpatient-reported outcome
dc.subjectprimary medical care
dc.subjectquality of life
dc.subjectrandomized controlled trial (topic)
dc.subjectvisual analog scale
dc.subjectallergic rhinitis
dc.subjectasthma
dc.subjectbreathing disorder
dc.subjectpatient care
dc.subjectrhinitis
dc.titlePatient-centered digital biomarkers for allergic respiratory diseases and asthma: The ARIA-EAACI approach – ARIA-EAACI Task Force Report
dc.typeArticle

Files

Collections

Scopus Koleksiyonu